Stock Scorecard



Stock Summary for Erasca Inc (ERAS) - $2.42 as of 11/3/2025 12:54:16 PM EST

Total Score

10 out of 30

Safety Score

29 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ERAS

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ERAS

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ERAS

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for ERAS

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for ERAS (29 out of 100)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 6
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 2
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 4
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for ERAS

Can Centene's Q3 Earnings Escape Industry's Cost Headwinds? 10/27/2025 5:09:00 PM
Will Lower Patient Days Affect Tenet Healthcare's Q3 Earnings? 10/23/2025 4:42:00 PM
Will Rising Costs Hurt HCA Healthcare Q3 Earnings? Key Estimates Here 10/21/2025 4:13:00 PM
Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Mr. Cooper Gr ( NASDAQ:COOP ) , Bolt Biotherapeutics ( NASDAQ:BOLT ) 10/2/2025 12:45:00 PM
This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Accenture ( NYSE:ACN ) , Academy Sports ( NASDAQ:ASO ) 9/3/2025 5:38:00 PM
Alphabet To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday - Annovis Bio ( NYSE:ANVS ) , Aptiv ( NYSE:APTV ) 9/3/2025 12:25:00 PM
Erasca Narrows Loss 46% in Fiscal Q2 8/13/2025 2:16:00 AM
Erasca to Present at Upcoming Investor Conferences in June 5/29/2025 12:00:00 PM
Erasca to Present at the Bank of America Securities Health Care Conference 5/7/2025 12:00:00 PM
Erasca Presents New Preclinical Data Reinforcing Best-in-Class Potential of RAS-Targeting Franchise at the 2025 AACR Annual Meeting - Erasca ( NASDAQ:ERAS ) 4/29/2025 8:05:00 PM

Financial Details for ERAS

Company Overview

Ticker ERAS
Company Name Erasca Inc
Country USA
Description N/A
Sector Name HEALTHCARE
Industry Name BIOTECHNOLOGY
Most Recent Quarter 6/30/2025
Next Earnings Date 11/5/2025

Stock Price History

Last Day Price 2.42
Price 4 Years Ago 15.58
Last Day Price Updated 11/3/2025 12:54:16 PM EST
Last Day Volume 1,475,380
Average Daily Volume 1,985,068
52-Week High 3.31
52-Week Low 1.01
Last Price to 52 Week Low 139.60%

Valuation Measures

Trailing PE N/A
Industry PE 22.87
Sector PE 106.79
5-Year Average PE -4.70
Free Cash Flow Ratio 10.52
Industry Free Cash Flow Ratio 14.55
Sector Free Cash Flow Ratio 28.77
Current Ratio Most Recent Quarter 11.04
Total Cash Per Share 0.23
Book Value Per Share Most Recent Quarter 1.31
Price to Book Ratio 1.62
Industry Price to Book Ratio 29.98
Sector Price to Book Ratio 32.17
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 32.76
Sector Price to Sales Ratio Twelve Trailing Months 16.57
Analyst Buy Ratings 4
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 283,670,000
Market Capitalization 686,481,400
Institutional Ownership 81.91%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -29.28%
Reported EPS 12 Trailing Months -0.39
Reported EPS Past Year -0.23
Reported EPS Prior Year -0.74
Net Income Twelve Trailing Months -128,274,000
Net Income Past Year -161,650,000
Net Income Prior Year -125,042,000
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%
Operating Margin Twelve Trailing Months 0.00%

Balance Sheet

Total Cash Most Recent Quarter 66,143,000
Total Cash Past Year 67,739,000
Total Cash Prior Year 93,075,000
Net Cash Position Most Recent Quarter 66,143,000
Net Cash Position Past Year 67,739,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 423,499,000
Total Stockholder Equity Prior Year 316,686,000
Total Stockholder Equity Most Recent Quarter 372,258,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -99,187,000
Free Cash Flow Per Share Twelve Trailing Months -0.35
Free Cash Flow Past Year -109,477,000
Free Cash Flow Prior Year -102,992,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.10
MACD Signal 0.14
20-Day Bollinger Lower Band 0.97
20-Day Bollinger Middle Band 1.78
20-Day Bollinger Upper Band 2.59
Beta 1.18
RSI 54.78
50-Day SMA 1.80
150-Day SMA 2.37
200-Day SMA 3.90

System

Modified 10/31/2025 10:37:08 PM EST